Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Espergærde Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.3% 1.6% 1.9% 1.4% 1.6% 1.3% 10.9% 10.7%   Credit score (0-100)   83 75 71 76 74 78 22 23   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   48.3 6.1 1.3 21.1 9.7 51.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,277 4,703 5,114 5,208 5,380 5,532 0.0 0.0   EBITDA   1,123 1,597 565 1,632 1,723 1,427 0.0 0.0   EBIT   920 1,365 330 1,378 1,454 1,160 0.0 0.0   Pre-tax profit (PTP)   922.2 1,364.4 324.2 1,373.8 1,446.3 1,159.9 0.0 0.0   Net earnings   718.2 1,063.2 252.4 1,070.1 1,125.8 900.5 0.0 0.0   Pre-tax profit without non-rec. items   922 1,364 324 1,374 1,446 1,160 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   146 327 319 426 308 241 0.0 0.0   Shareholders equity total   1,018 1,781 1,434 1,754 1,880 1,780 480 480   Interest-bearing liabilities   0.0 49.7 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,271 3,110 4,029 2,687 2,714 2,737 480 480   Net Debt   -772 -1,498 -2,253 -1,066 -1,417 -1,542 -178 -178     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,277 4,703 5,114 5,208 5,380 5,532 0.0 0.0   Gross profit growth   8.4% 10.0% 8.7% 1.8% 3.3% 2.8% -100.0% 0.0%   Employees   6 7 7 8 9 10 0 0   Employee growth %   0.0% 16.7% 0.0% 14.3% 12.5% 11.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,271 3,110 4,029 2,687 2,714 2,737 480 480   Balance sheet change%   -69.9% 37.0% 29.5% -33.3% 1.0% 0.9% -82.5% 0.0%   Added value   1,123.2 1,597.1 564.7 1,632.3 1,708.1 1,427.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -344 -202 -394 -298 -538 -486 -241 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   21.5% 29.0% 6.5% 26.5% 27.0% 21.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   18.8% 50.8% 9.4% 41.3% 53.9% 42.6% 0.0% 0.0%   ROI %   23.6% 82.9% 18.4% 78.6% 74.6% 60.4% 0.0% 0.0%   ROE %   20.5% 76.0% 15.7% 67.1% 62.0% 49.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   44.8% 57.3% 35.6% 65.3% 69.3% 65.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -68.8% -93.8% -399.1% -65.3% -82.2% -108.1% 0.0% 0.0%   Gearing %   0.0% 2.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 6.3% 51.6% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 1.4 1.1 1.6 2.1 1.9 0.0 0.0   Current Ratio   1.1 1.7 1.2 2.1 2.7 2.5 0.0 0.0   Cash and cash equivalent   772.2 1,547.7 2,253.4 1,065.5 1,417.0 1,542.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   53.1 756.6 544.6 876.9 1,230.8 1,307.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   187 228 81 204 190 143 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   187 228 81 204 191 143 0 0   EBIT / employee   153 195 47 172 162 116 0 0   Net earnings / employee   120 152 36 134 125 90 0 0